Press Releases
Accelerating sequence variant analysis in biologic drug development
By integrating sequence variant analysis (SVA) at strategic points within the cell line and process development workflows, Samsung Biologics not only reduces time and costs but also enhances the quality of the final product.
In the latest discussion with Contract Pharma, Kyoungmin Lee, Senior Scientist of Structure Analytics, shares the role SVA plays in biologics drug development, the capabilities and tools needed to accelerate SVA, address risks, and more.
Read on to learn about how we can be your strategic partner in drug development.
By integrating sequence variant analysis (SVA) at strategic points within the cell line and process development workflows, Samsung Biologics not only reduces time and costs but also enhances the quality of the final product.
In the latest discussion with Contract Pharma, Kyoungmin Lee, Senior Scientist of Structure Analytics, shares the role SVA plays in biologics drug development, the capabilities and tools needed to accelerate SVA, address risks, and more.
Read on to learn about how we can be your strategic partner in drug development.